SE9801704D0 - Biologically active composition - Google Patents

Biologically active composition

Info

Publication number
SE9801704D0
SE9801704D0 SE9801704A SE9801704A SE9801704D0 SE 9801704 D0 SE9801704 D0 SE 9801704D0 SE 9801704 A SE9801704 A SE 9801704A SE 9801704 A SE9801704 A SE 9801704A SE 9801704 D0 SE9801704 D0 SE 9801704D0
Authority
SE
Sweden
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
SE9801704A
Other languages
English (en)
Swedish (sv)
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Heiman
Rikard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Priority to SE9801704A priority Critical patent/SE9801704D0/xx
Publication of SE9801704D0 publication Critical patent/SE9801704D0/xx
Priority to IL13957699A priority patent/IL139576A0/xx
Priority to PL99344051A priority patent/PL344051A1/xx
Priority to AT99927061T priority patent/ATE310500T1/de
Priority to CN99808547A priority patent/CN1309553A/zh
Priority to JP2000547960A priority patent/JP2002514587A/ja
Priority to PCT/SE1999/000823 priority patent/WO1999058108A1/fr
Priority to TR2000/03589T priority patent/TR200003589T2/xx
Priority to DE1082102T priority patent/DE1082102T1/de
Priority to ES99927061T priority patent/ES2155048T3/es
Priority to EP99927061A priority patent/EP1082102B1/fr
Priority to KR1020007012708A priority patent/KR100592971B1/ko
Priority to NZ508073A priority patent/NZ508073A/xx
Priority to AU44050/99A priority patent/AU736480B2/en
Priority to HU0102426A priority patent/HUP0102426A2/hu
Priority to DE69928524T priority patent/DE69928524T2/de
Priority to US09/700,176 priority patent/US6537576B1/en
Priority to CA2331527A priority patent/CA2331527C/fr
Priority to ZA200006474A priority patent/ZA200006474B/xx
Priority to IL139576A priority patent/IL139576A/en
Priority to NO20005724A priority patent/NO20005724L/no
Priority to GR20010300013T priority patent/GR20010300013T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9801704A 1998-05-14 1998-05-14 Biologically active composition SE9801704D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
CA2331527A CA2331527C (fr) 1998-05-14 1999-05-12 Composition biologiquement active
EP99927061A EP1082102B1 (fr) 1998-05-14 1999-05-12 Composition biologiquement active
NZ508073A NZ508073A (en) 1998-05-14 1999-05-12 Biologically active composition
AT99927061T ATE310500T1 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung
CN99808547A CN1309553A (zh) 1998-05-14 1999-05-12 生物活性组合物
JP2000547960A JP2002514587A (ja) 1998-05-14 1999-05-12 生物活性組成物
PCT/SE1999/000823 WO1999058108A1 (fr) 1998-05-14 1999-05-12 Composition biologiquement active
TR2000/03589T TR200003589T2 (tr) 1998-05-14 1999-05-12 Biyolojik olarak aktif bileşim.
DE1082102T DE1082102T1 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung
ES99927061T ES2155048T3 (es) 1998-05-14 1999-05-12 Composicion biologicamente activa.
IL13957699A IL139576A0 (en) 1998-05-14 1999-05-12 Biologically active composition
KR1020007012708A KR100592971B1 (ko) 1998-05-14 1999-05-12 생물학적 활성 조성물
PL99344051A PL344051A1 (en) 1998-05-14 1999-05-12 Biologically active composition
AU44050/99A AU736480B2 (en) 1998-05-14 1999-05-12 Biologically active composition
HU0102426A HUP0102426A2 (hu) 1998-05-14 1999-05-12 Biológiailag aktív készítmény
DE69928524T DE69928524T2 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung
US09/700,176 US6537576B1 (en) 1998-05-14 1999-05-12 Biologically active composition
IL139576A IL139576A (en) 1998-05-14 2000-11-09 A biologically active preparation and a method for its preparation
ZA200006474A ZA200006474B (en) 1998-05-14 2000-11-09 Biologically active composition.
NO20005724A NO20005724L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning
GR20010300013T GR20010300013T1 (en) 1998-05-14 2001-04-30 Biologically active composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Publications (1)

Publication Number Publication Date
SE9801704D0 true SE9801704D0 (sv) 1998-05-14

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Country Status (20)

Country Link
US (1) US6537576B1 (fr)
EP (1) EP1082102B1 (fr)
JP (1) JP2002514587A (fr)
KR (1) KR100592971B1 (fr)
CN (1) CN1309553A (fr)
AT (1) ATE310500T1 (fr)
AU (1) AU736480B2 (fr)
CA (1) CA2331527C (fr)
DE (2) DE69928524T2 (fr)
ES (1) ES2155048T3 (fr)
GR (1) GR20010300013T1 (fr)
HU (1) HUP0102426A2 (fr)
IL (2) IL139576A0 (fr)
NO (1) NO20005724L (fr)
NZ (1) NZ508073A (fr)
PL (1) PL344051A1 (fr)
SE (1) SE9801704D0 (fr)
TR (1) TR200003589T2 (fr)
WO (1) WO1999058108A1 (fr)
ZA (1) ZA200006474B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280485A4 (fr) * 2000-02-29 2006-11-29 Zars Inc Timbre transdermique pour medicament ameliore
CA2653782A1 (fr) * 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Compositions locales
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
CA2739380C (fr) * 2008-10-06 2014-12-09 Mylan Technologies, Inc. Systeme transdermique de rotigotine amorphe
CA2902795C (fr) 2013-02-28 2021-06-15 Dermira, Inc. Sels de glycopyrrolate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
DE69928524D1 (de) 2005-12-29
ES2155048T1 (es) 2001-05-01
NO20005724D0 (no) 2000-11-13
DE1082102T1 (de) 2001-09-06
IL139576A (en) 2007-07-04
ZA200006474B (en) 2001-09-04
EP1082102B1 (fr) 2005-11-23
CA2331527C (fr) 2010-04-13
TR200003589T2 (tr) 2001-03-21
AU736480B2 (en) 2001-07-26
ES2155048T3 (es) 2006-06-16
EP1082102A1 (fr) 2001-03-14
CN1309553A (zh) 2001-08-22
GR20010300013T1 (en) 2001-04-30
IL139576A0 (en) 2002-02-10
CA2331527A1 (fr) 1999-11-18
NO20005724L (no) 2001-01-09
DE69928524T2 (de) 2006-08-10
KR20010052348A (ko) 2001-06-25
PL344051A1 (en) 2001-09-24
ATE310500T1 (de) 2005-12-15
WO1999058108A1 (fr) 1999-11-18
KR100592971B1 (ko) 2006-06-23
US6537576B1 (en) 2003-03-25
HUP0102426A2 (hu) 2002-03-28
NZ508073A (en) 2002-12-20
JP2002514587A (ja) 2002-05-21
AU4405099A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
DE69033994T2 (de) Flüssige Polymerzusammensetzung und Verfahren zu ihrer Verwendung
JPS57192463A (en) Polymer film having maleic anhydride residue
TR199900353T2 (xx) Kontroll� salma sa�layan cihazlar�n yap�m� i�in y�ntem.
BR0016828A (pt) Polìmeros superabsorventes
NO954957L (no) Synergistisk stabiliserte flytende enzymatiske blandinger
ATE310500T1 (de) Biologisch aktive zusammensetzung
NO20005725D0 (no) Biologisk aktiv sammensetning
KR920012357A (ko) 접착제 조성물 및 금속 접합체
JPS5687519A (en) Drug pharmaceutical
TR200000442T2 (tr) Sıvı deterjan bileşimleri ve bunları hazırlamak için işlem.
KR860008946A (ko) 수처리 조성물
RU96102520A (ru) Способ обработки скважины
Pagga Biodegradation of Substances at Low Concentrations(Biologischer Abbau von Stoffen bei Geringen Konzentrationen)
JPS5233355A (en) Waste water (or solution) treatment method
KR930012035A (ko) 소마토트로핀을 함유하는 지속성 조성물
TH25177B (th) การปรับปรุงในหรือเกี่ยวข้องกับกรรมวิธีหนึ่ง
TH18948A (th) สารผสมสำหรับซักฟอก
TH25177A (th) การปรับปรุงในหรือเกี่ยวข้องกับกรรมวิธีหนึ่ง
TH16465A (th) สูตรผสมสารเริ่มต้นสารฟอกจางเพอร์ออกซิแอซิคทีเคลือบไว้